Factors related to biologic behavior in giant cell tumor of bone

Chinese Journal of Pathology

Volumn 42, Issue 10, 2013, Pages 669-674

  Ran, Xiang Ying ^a   Huang, Jin ^a   Zhang, Hui Zhen ^a   Jiang, Zhi Ming ^a   Chen, Jie ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Bone neoplasms; Diagnosis; Differential; Giant cell tumors

Indexed keywords

BSG PROTEIN, HUMAN; CD147 ANTIGEN; CKAP4 PROTEIN, HUMAN; MEMBRANE PROTEIN; PGM1 PROTEIN, HUMAN; PHOSPHOGLUCOMUTASE; PROTEIN P53; TP53 PROTEIN, HUMAN;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; FEMALE; FOLLOW UP; HUMAN; MALE; METABOLISM; MIDDLE AGED; OSTEOCLASTOMA; OSTEOSARCOMA; PATHOLOGY; RADIOGRAPHY; TUMOR INVASION; TUMOR RECURRENCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD147; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; FOLLOW-UP STUDIES; GIANT CELL TUMOR OF BONE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PHOSPHOGLUCOMUTASE; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84890318570     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2013.10.006     Document Type: Article

References (14)

1. Wuelling M, Engels C, Jesse N., et al Histogenesis of giant cell tumors. Pathologe, 2002, 23(5): 332-339.
2. Zheng MH, Robbins P, Xu J., et al The histogenesis of giant cell tumour of bone: a model of interaction between neoplastic cells and osteoclasts. Histol Histopathol, 2001, 16(1): 297-307.
3. Chert MA, Rizzo M, Harrelson J.M., et al Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res, 2002(400): 201-210.
4. Masui F, Ushigome S, Fujii K. Giant cell tumor of bone: a clinicopathologic study of prognostic factors. Pathol Int, 1998, 48 (9): 723-729.
5. Rock M. Curettage of giant cell tumor of bone. Factors influencing local recurrences and metastasis. Chir Organi Mov, 1990, 75(1 Suppl): 204-205.
6. Boutou-Bredaki S., Agapios P, Papachristou G. Prognosis of giant cell tumor of bone. Histopathological analysis of 15 cases and review of the literature. Adv Clin Path, 2001, 5(3): 71-78.
7. Campanacci M, Baldini N, Boriani S., et al Giant-cell tumor of bone. J Bone Joint Surg, 1987, 69(1): 106-114.
8. Lee CH, Espinosa I, Jensen K.C., et al Gene expression profiling identifies p63 as a diagnostic marker for giant cell tumor of the bone. Mod Pathol, 2008, 21(5): 531-539.
9. Sun J, Hemler ME Regulation of M MP-1 and MMP-2 production through CD147/extracellular matrix metalloproleinase inducer interactions. Cancer Res, 2001, 61(5): 2276-2281.
10. Biswas C, Zhang Y, Decastro R., et al The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res, 1995, 55 (2): 434-439.
11. Ren K, Shi X, Wu S. Giant cell tumor of the proximal femur: diagnosis and surgical outcomes. Orthopedic J Chin, 2012, 20: 577-580.
12. Balke M, Campanacci L, Gebert C., et al Bisphosphonate treatment of aggressive primary, recurrent and metastatic giant cell tumour of bone. BMC Cancer, 2010, 10: 462.
13. Thomas D, Henshaw R, Skubitz K., et al Denosumab in patients with giant-cell tumour of bone; an open-label, phase 2 study. Lancet Oncol, 2010, 11(3): 275-280.
14. Dickson BC, Li S Q, Wunder JS, et al Giant cell tumor of bone express p63. Mod Pathol, 2008, 21(4): 369-375.